“…Abstinence-reinforcing contingency management (CM) (financial incentives contingent on drug-free urine) leads to reduction in illicit opioid and cocaine use (Giuffrida and Torgerson, 1997;Griffith et al, 2000;Higgins et al, 2000;Lussier et al, 2006;Prendergast et al, 2006;Preston et al, 2000Preston et al, , 2002Schottenfeld et al, 2005;Silverman et al, 1996aSilverman et al, , 1996bSilverman et al, , 1998Silverman et al, , 2004. Due to the success of abstinence-reinforcing CM, other studies have used CM to optimize HIV outcomes (Bassett et al, 2015;El-Sadr et al, 2017;Farber et al, 2013;Metsch et al, 2016;Rigsby et al, 2000;Rosen et al, 2007;Silverman et al, 2019;Solomon et al, 2014;Sorensen et al, 2007). Of seven randomized trials that tested the effect of CM interventions on HIV outcomes, three reinforced ARV adherence (Rigsby et al, 2000;Rosen et al, 2007;Sorensen et al, 2007), one reinforced VL suppression (Silverman et al, 2019), one reinforced linkage to HIV care and VL suppression (with two separate CM interventions) (El-Sadr et al, 2017), and two reinforced several different behaviors including attending patient navigation sessions, HIV clinic visits, HIV blood tests, ARV initiation, VL suppression, substance use disorder treatment, or drug-free lab tests (Metsch et al, 2016;Solomon et al, 2014).…”